The Pharmacological Potential of Cyanobacteria

Graciliana Lopes is a pharmacist, with specialization in Phytochemistry and Pharmacognosy, and with a strong background in biological assays in cell and cell-free systems, and mechanisms of action of drugs. Her research has been most devoted to the fields of inflammation, microbiology, oxidative stress and chromatography. Marisa Silva is a Biologist has a strong background in marine toxins and in chromatographic techniques, with emphasis on LC-MS/MS. Her research contributed to the update of EFSA’s recommendations regarding emergent marine toxins monitoring and public health risk hazard. Department of Biology the Faculty of Sciences , Porto University and the head of the Laboratory of Ecotoxicology, Genomics and Evolution (LEGE) at the Marine and Environmental Research Center (CIIMAR) of Porto University, Portugal

1. Trends in Cyanobacteria: A contribution to systematics and biodiversity studies 2. Specialized Metabolites from Cyanobacteria and their Biological Activities 3. Cyanobacterial anti-cancer compounds in clinical use. Lessons from the dolastatins and cryptophycins 4. Anti-inflammatory activity of cyanobacteria 5. UV-protective secondary metabolites from cyanobacteria 6. Antimicrobial activity of Cyanobacteria-derived compounds 7. The role of toxins: Impact on human health and aquatic environments 8. Cyanobacterial pigments: photosynthetic function and biotechnological purposes 9. Cyanobacteria in cosmetic: a natural alternative for anti-aging ingredients 10. The nutraceutical potential of cyanobacteria